Pubblicato il

Global RNA Transcriptomics Market Set for 13.6% CAGR Growth

RNA Analysis Market

According to the latest market research study published by P&S Intelligence, the global RNA analysis/transcriptomics market is poised for significant growth, projected to reach USD 16.2 billion by 2032, up from USD 5.9 billion in 2024, advancing at a CAGR of 13.6% during 2025–2032. This expansion is fueled by the increasing adoption of personalized medicine, heightened government funding for omics research, and rising investments in pharmaceutical and biotech R&D. The proliferation of RNA sequencing applications and the introduction of innovative transcriptomics products by numerous key players are also pivotal in propelling market growth.​

Technological advancements, such as antisense technology, SMaRT technology, and RNA interference, are expected to offer substantial opportunities for companies developing RNA-based therapies and vaccines. Furthermore, the integration of artificial intelligence (AI) and machine learning (ML) into RNA analysis is enhancing data interpretation and streamlining workflows, enabling more rapid and accurate results.​

Key Insights

Segmentation Analysis

  • The market is segmented by product into consumables, instruments, and software.
  • By technology, it includes next-generation sequencing, polymerase chain reaction, microarray, and mass cytometry.
  • Applications encompass drug discovery and development, diagnostics, cell biology, single-cell analysis, and gene expression.
  • End users are categorized into academic and research institutions, and biotechnology and biopharmaceutical companies.​

Download free report sample at: https://www.psmarketresearch.com/market-analysis/rna-analysis-transcriptomics-market/report-sample

Regional and Geographical Trends

  • North America holds the largest market share, attributed to advanced healthcare infrastructure and significant R&D investments.
  • Asia-Pacific is the fastest-growing region, driven by increasing government initiatives and expanding biotech sectors.​

Technological Advancements Shaping the Market

  • The integration of AI and ML in RNA analysis is a key trend, enhancing data interpretation and enabling the discovery of new biomarkers.
  • Emerging technologies like antisense, SMaRT, and RNA interference are creating new avenues for RNA-based therapies and vaccines.​

Competitive Dynamics, Major Players, and Emerging Opportunities

  • The market is fragmented, with numerous key players developing innovative transcriptomics products.
  • Companies are focusing on integrating advanced technologies to enhance analytical capabilities and provide rapid, accurate results.
  • The growing demand for personalized medicine and targeted therapies presents significant opportunities for market expansion.
Pubblicato il

Patient Referral Management Software Market Set for 17.9% CAGR Through 2030

According to the latest market research study published by P&S Intelligence, the global patient referral management software market was valued at USD 9,598.3 million in 2023 and is expected to experience robust growth, with a CAGR of 17.9% from 2024 to 2030, reaching USD 30,221.2 million by the end of the forecast period. This growth is primarily driven by an aging global population, increased government initiatives promoting healthcare IT adoption, and continuous technological advancements. The software’s role in streamlining referral processes, enhancing communication among healthcare professionals, and improving patient care quality is also a significant factor supporting its widespread adoption.

Technological innovations, such as cloud-based solutions, electronic prescriptions, and integrated health records, further enhance the efficiency and accuracy of patient referral management. These advancements are poised to address the challenges of referral leakage, patient tracking, and communication barriers, thus contributing to the market’s expansion.

Key Insights

The patient referral management software market is segmented into software and services, with the software category holding the largest share in 2023. It is expected to grow rapidly due to its enhanced accuracy and efficiency in managing healthcare operations.

The inbound referrals segment is projected to witness the fastest growth, with a CAGR of 17.9% from 2024 to 2030, as hospitals increasingly utilize digital platforms to handle the influx of referrals.

Cloud-based solutions are expected to dominate the market, thanks to their cost-efficiency, scalability, and better data security compared to on-premises systems. Healthcare providers are increasingly adopting cloud solutions for their operational flexibility.

The providers category is expected to be the largest and fastest-growing end-user segment, advancing at a CAGR of 18.2%. Healthcare providers benefit from improved coordination, reduced referral leakage, and automated processes, ultimately enhancing operational efficiency.

North America holds the largest market share, with strong growth driven by the region’s advanced healthcare infrastructure, increasing adoption of telehealth, and growing use of artificial intelligence and data analytics in healthcare.

Geriatric care is a significant driver for the market, as the elderly population requires efficient, timely access to specialized healthcare. Referral management software ensures better coordination and care for the aging population.

Technological developments, including the integration of electronic health records and the rise of digital health solutions, are key factors accelerating market growth, optimizing referral processes, and improving overall patient satisfaction.

About P&S Intelligence

P&S Intelligence offers custom and syndicated market research and consulting services to clients across the globe. Our team of young and dynamic researchers, guided by mentors with years of experience, create data-rich reports tailored to the needs of MNCs as well as startups and SMEs. We remain in a perennial quest to offer exhaustive insights into every aspect of the market, allowing businesses of all sizes to seize even the smallest of opportunities and tackle even the biggest of challenges.

Contact:
Chandra Mohan
AVP – Business Development
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Follow Us: LinkedIn Twitter

Pubblicato il

Gene Cloning Services Demand Surges Amid Biotech Growth

Gene Cloning Services Market

According to the latest market research study published by P&S Intelligence, the global gene cloning services market is experiencing remarkable growth, with its value estimated at USD 3,154.1 million in 2023 and projected to reach USD 10,019.6 million by 2030, reflecting a robust CAGR of 18.1% during the forecast period.

This surge is primarily driven by the increasing prevalence of chronic diseases, a heightened demand for precision medicine, and significant advancements in genetic research. The rise in healthcare expenditure by governments, coupled with the expansion of the biotechnology industry, further propels the market’s growth. ​

Key Insights

Service Segmentation

The gene cloning services market is categorized into custom cloning, molecular biology, and gene synthesis services. Among these, custom cloning services hold a substantial share, attributed to their tailored solutions catering to specific research and therapeutic needs.​

Application Spectrum

Gene cloning finds extensive applications across various domains:​

  • Gene Therapy: Utilized in correcting defective genes responsible for disease progression.​
  • Vaccine Research: Plays a pivotal role in developing recombinant vaccines, enhancing immunogenicity and safety profiles.​
  • Agricultural Sector: Employed in creating genetically modified crops with improved yield and resistance to pests.​

Gene Type Analysis

The market differentiates between standard and complex genes. Complex gene cloning services are witnessing increased demand due to the intricate nature of multi-gene disorders and the necessity for comprehensive therapeutic strategies.​

End-User Dynamics

The primary consumers of gene cloning services include:​

  • Clinical Laboratories: Rely on cloning techniques for accurate disease diagnosis and research.​
  • Pharmaceutical & Biotechnology Firms: Utilize these services for drug discovery, development, and personalized medicine approaches.​

Regional Trends

North America leads the market, driven by advanced healthcare infrastructure, substantial research funding, and a high adoption rate of innovative technologies. Europe follows suit, with significant contributions to biotechnology research. The Asia-Pacific region is emerging rapidly, attributed to increasing investments in healthcare and biotechnology sectors.​

Technological Advancements

Innovations such as CRISPR-Cas9 and other gene-editing technologies have revolutionized gene cloning, making processes more efficient and cost-effective. These advancements facilitate precise modifications, thereby broadening the scope of therapeutic applications.​

Competitive Landscape

The market is characterized by the presence of key players offering a wide range of services. Companies are focusing on strategic collaborations, mergers, and acquisitions to enhance their service portfolios and global reach.​

Emerging Opportunities

The rising focus on personalized medicine and the increasing prevalence of genetic disorders present lucrative opportunities. Additionally, the agricultural sector’s demand for genetically modified organisms (GMOs) to ensure food security opens new avenues for market expansion.​

Pubblicato il

Tech Innovations Driving Endodontic Devices Market Growth

Endodontic Devices Market

The global endodontic devices market is poised for significant growth, with revenues projected to increase from $1.8 billion in 2024 to $3.0 billion by 2032, reflecting a compound annual growth rate (CAGR) of 6.1% during the forecast period of 2025–2032. This upward trajectory is primarily driven by the rising prevalence of dental infections and the burgeoning dental tourism industry.

Key Insights

Market Segmentation

The market is categorized into instruments and consumables. Dental clinics represent the largest end-user segment, underscoring the critical role these facilities play in delivering endodontic care.

Regional Trends

North America currently holds the largest market share, attributed to advanced healthcare infrastructure and a high incidence of dental issues. However, the Asia-Pacific region is anticipated to experience the fastest growth, driven by increasing healthcare investments and heightened awareness of dental health.

Technological Advancements

Innovations such as nickel-titanium rotary instruments, 3D imaging systems, electronic apex locators, and laser-assisted root canal treatments are revolutionizing endodontic procedures. These advancements enhance treatment precision, speed, and safety, leading to improved patient outcomes and reduced treatment durations.

Competitive Landscape

The market is fragmented, featuring numerous regional players specializing in products tailored to local demands. This diversity allows companies to address specific needs effectively. Key industry participants include Danaher Corporation, Dentsply Sirona, FKG Dentaire Sàrl, Ivoclar Vivadent AG, Septodont, Ultradent Products Inc., COLTENE Group, Peter Brasseler Holdings LLC, and DiaDent Group International.

Emerging Opportunities

The increasing global elderly population, who are more susceptible to dental issues requiring endodontic treatment, presents significant growth opportunities. Additionally, the trend toward minimally invasive procedures is driving demand for advanced endodontic technologies that offer quicker, more efficient, and less invasive treatments.

In summary, the endodontic devices market is on a robust growth path, propelled by technological innovations, demographic shifts, and evolving patient preferences toward advanced and efficient dental care solutions.

Pubblicato il

How Does the Rise in Geriatric Population Contribute to Revenue of Patient Temperature Monitoring Industry?

Patient Temperature Monitoring Market

In 2021, the patient temperature monitoring market generated $3,294.8 million in revenue, and it is expected to grow to $6,039.3 million by 2030, advancing at a 7% rate. This growth is driven by the increasing demand for non-invasive, non-traumatic, and hygienic devices that provide accurate temperature readings. Handheld temperature monitoring devices hold a 27% share of the market, thanks to the convenience they offer patients.

The rising prevalence of chronic and infectious diseases like diabetes, cancer, and cardiovascular conditions is further driving the demand for temperature monitoring devices. It is estimated that over the next decade, chronic diseases will claim 5 million lives in the U.K., underscoring the importance of regular temperature monitoring for effective disease management.

In the U.S., as of 2020, 6 out of 10 people had at least one chronic condition, while 4 out of 10 had two or more. This makes temperature monitoring vital for early diagnosis. The link between temperature fluctuations and the occurrence of illnesses is expected to boost demand for temperature monitoring systems.

The COVID-19 pandemic has significantly boosted the temperature monitoring market due to the rising need for such devices. Manufacturers are increasing the production of digital thermometers, which provide accurate and reliable temperature readings. These devices now feature improved technology, reducing errors and fluctuating results. For instance, in February 2020, Xiaomi introduced a non-contact infrared thermometer capable of measuring temperature in just one second with an accuracy of 0.2 degrees.

Non-invasive temperature monitoring systems account for a substantial portion of the market, generating $1,892.9 million in revenue, with a projected growth rate of 7.3%. The demand for non-invasive devices is increasing due to their ease of use, accurate readings, and user comfort.

The growing demand for oral temperature monitoring is driving the sales of oral thermometers, offering an opportunity for manufacturers to introduce new products. Additionally, temporal artery and axillary thermometers are gaining popularity for their simplicity, quick results, and minimal invasiveness, further boosting the market.

Within the application segment, fever management (pyrexia) drives the highest demand, accounting for a 30.1% market share. The rise in the elderly population, coupled with trauma and hemolysis cases, is fueling the demand for temperature monitoring equipment. Fever, often accompanied by fatigue, dehydration, and increased pain sensitivity, is becoming more prevalent, further supporting the market’s growth.

North America is a key region for patient temperature monitoring systems, generating $1,077.0 million in revenue. The market here is expected to grow at a rate of 6.9%, driven by the presence of major industry players, high disposable income, increased surgical procedures, and rising blood donations and transfusions.

Overall, the growing prevalence of chronic and infectious diseases, with high body temperature as a major symptom, continues to propel the patient temperature monitoring industry forward.

Pubblicato il

Pharmaceutical Analytical Testing Outsourcing Market Set for 9% Growth by 2030

Pharmaceutical Analytical Testing Outsourcing Market

The global pharmaceutical analytical testing outsourcing market was valued at $7,594.3 million in 2021 and is projected to grow at a rate of approximately 9%, reaching around $15,815 million by 2030. This growth is driven by advancements in the pharmaceutical sector, increased focus on safety and regulatory compliance, rising demand for testing services, and cost advantages of outsourcing.

The demand for bioanalytical services is expected to rise significantly, influenced by evolving regulations for in-vitro and in-vivo testing, as well as the complexities of these assessments. The growing need for biosimilars, combination therapies, and novel drugs has amplified the requirement for specialized tests such as electrochemical, electrophoresis, titrimetric assays, and immunoassays.

Pharmaceutical companies accounted for 48% of the market share historically, as many lack the resources to conduct in-house testing. Outsourcing analytical testing allows these companies to focus on core operations while saving time and resources. In the future, biopharmaceutical firms are expected to grow at the fastest rate, around 9%. These businesses require analytical testing for optimizing production, ensuring quality in biosimilars and biologics, and fulfilling regulatory requirements. The increasing demand for expert personnel to perform assays and handle regulatory filings is further driving the outsourcing trend in the biopharmaceutical sector.

North America held the largest share of the market, about 53%, due to its advanced pharmaceutical manufacturing hubs and increasing production to meet healthcare demands. Europe’s market is thriving with the adoption of cutting-edge microbial manufacturing technologies, while emerging nations collaborate with Western companies to build local capacities through services like clinical research and drug development.

Meanwhile, the Asia-Pacific region is expected to witness the fastest growth, driven by significant investments, expansion in the pharmaceutical industry, and the presence of major outsourcing centers in China, India, and the Philippines. China has become a preferred outsourcing destination for Japan’s nearshore and onshore clients due to its attractive delivery capabilities.

With rising drug consumption and increasing R&D activities, the demand for pharmaceutical analytical testing outsourcing continues to grow globally.

Pubblicato il

Medical Billing Outsourcing Market Doubles by 2030 as Digital Healthcare Grows

Medical Billing Outsourcing Market

In 2024, the medical billing outsourcing industry size stood at USD 15.6 billion, and it is projected to advance at a CAGR of 12.3% over the projection period, to attain USD 31.4 billion by the end of 2030.

The growth can be credited to the growing utilization of IT resources in the medical business, the increasing funding and also schemes from governments, and the increasing use of medical billing outsourcing services by hospitals, doctors, and other healthcare services, credited to their advantages.

The market for medical billing outsourcing is growing due to several key factors. There’s a rise in medical prescriptions globally, driven by increasing incidences of chronic and infectious diseases and higher hospital admissions. The COVID-19 pandemic further accelerated this trend, boosting demand for medical billing outsourcing as hospitalization rates surged. This heightened the need for robust, scalable, and collaborative digital healthcare infrastructure.

Digitalization and outsourcing have led to increased demand for advanced software technology for medical billing and patient database management. There’s also a growing adoption of electronic health records for patient care and billing purposes.

Rapidly rising demand for telemedicine or telehealth is among several trends seen in the outsourcing of medical billing. Most of the common health care services like consultation, diagnosis, discussion of health issues, treatment, and follow-up can be delivered at a distance with the help of telecommunication equipment like audio/video communicators.

Key Insights

  • Front-end services hold a substantial industry share because of their role in preregistration, registration, scheduling, insurance verification, eligibility checks, and pre-authorization, improving efficiency and patient satisfaction.
  • Middle-end services is projected to advance significantly with new entrants and augmented awareness among healthcare practitioners.
  • Out-patient bills are estimated to advance at a CAGR of 12.6%, propelled by minor injuries, outpatient operations, and improvements in medical technology.
  • The large hospital category leads the market with a 50% share in 2030, credited to their acceptance of electronic health records (EHRs) and the requirement for error-free billing processes.
  • The hospital category dominates the industry in terms of end users, propelled by the growing load of patient records management and increasing reimbursement complexities.
  • Physician offices are expected to proliferate, driven by increased healthcare spending, regulatory compliance needs, and cost reduction efforts through outsourcing.
  • North America leads the global market with a 55% revenue share in 2023, driven by technological advancements, R&D investments, and the presence of major industry players focused on customer satisfaction and service quality.
  • The adoption of medical billing outsourcing is increasing among healthcare providers due to the complexity introduced by the International Classification of Diseases-10th revision (ICD-11), driving demand for robust revenue cycle management (RCM) solutions integrated with electronic medical records (EMRs).
  • Physician offices are focusing on outsourcing to manage healthcare billing errors and operational costs, with approximately 15% of physician earnings spent on billing errors and 25% of revenue allocated to billing processes.
Pubblicato il

Increasing Chronic Pain and Smoking Rates Propel Transdermal Drug Delivery Market Growth

The total value of the transdermal drug delivery systems market was USD 4.2 billion in 2023. It is expected to grow at a CAGR of 4.7%, reaching USD 5.8 billion by 2030. This market is primarily driven by the increasing prevalence of chronic illnesses, as traditional drug delivery systems are less effective due to hepatic first-pass metabolism. This process results in oral drugs being mostly broken down in the liver before they can reach their target tissues, reducing their efficacy.

Globally, more than one billion people smoke cigarettes, and despite international and national efforts to monitor, educate, and restrict supply, smoking rates remain high. This drives the demand for transdermal nicotine patches, which have been shown to be 50–60% more effective than placebos in helping individuals quit smoking over a year.

The iontophoresis technology segment leads the market, as it enhances skin penetration and accelerates the release rate of drugs with poor absorption or infusion. The pain management segment is also a major market driver, due to the increasing prevalence of chronic pain from conditions such as amputations, arthritis, and nervous system disorders. An estimated 20% of the global adult population suffers from chronic pain, which significantly impacts productivity and causes emotional and psychological distress. Consequently, transdermal analgesia is gaining popularity.

North America dominates the transdermal drug delivery systems market, driven by patent expirations that allow more companies to enter the market with generic alternatives. Additionally, the relaunch of previously failed drugs for subcutaneous delivery and substantial R&D investments contribute to the region’s significant market share. In Europe, the market is supported by favorable insurance policies and awareness campaigns by government institutions. The region’s advanced healthcare infrastructure and strong public health focus, along with numerous medical device and R&D institutes, facilitate the rapid adoption of innovative healthcare technologies.

The global demand for transdermal drug delivery systems is rising due to the increasing incidence of chronic illnesses, a trend that is expected to continue in the coming years.

Pubblicato il

Need for Hygienic Work Environment Drives the Professional Hygiene Market

Professional Hygiene Market

The size of the professional hygiene market will grow at a rate of 5.10% by the end of this decade, to touch USD 23,953 million by 2030.

Because of the increase in populace, shift of individuals from urban to rural areas, and surge in tourism actions, the requirement for hygiene upkeep products is increasing in the hospitality industry, which had about 40% share in the industry in the past.

The category comprises of motels, hotels, spas, food service providers, beauty salons, and other spaces where guests’ accommodation and other personal needs are catered to. One of the straightforward things that visitors expect at these places is good cleansing and hygiene.

The main driver for the development of the tissues and napkins category is the snowballing consciousness of hand hygiene in workplaces and increasing occurrence of HAIs. At hotels, hospitals, and offices, tissue and napkins are the most used products for hand drying; so, they had over 81% share in the professional hygiene market in the recent past.

Also, the progressions in the tech of making tissues, advent of organic tissue paper and cutting-edge ways of dispensing, increasing incomes, and initiatives of the government to support public health are driving the development of the industry.

The use of tissues in washrooms because of need, overall Westernization of the washroom culture, snowballing consciousness of hygiene and sanitation, and mounting living standard have augmented the requirement for finest sanitary products, for further ease.

It is due to the rising need for hygienic work environment, the demand for professional hygiene solutions will continue to grow in the years to come as well.

Pubblicato il

Wound Care Biologics: A Rising & Advanced Trend in New Wound Care

Wound Care Biologics

Biologics, or biological medical products, are the treatment products that are produced from living cells or organisms. The improvement in the technology of wound care has resulted in the arrival of biotechnology in wound care.

Wound healing is a complicated procedure that comprises the dynamic interplay of different mediators like growth factors, cellular & extracellular components, and matrix metalloproteinases. Wound care biotechnology targets these aspects that are affected in chronic wounds. Some major wound care biological products are:

Skin Substitutes

Skin substitutes are tissue-engineered products employed to manage chronic non-healing wounds. These products can be utilized to either temporarily or permanently cover the wound bed. Skin substitutes are classified into either cellular and acellular products.

Cellular products are composed of living cells comprised inside a matrix, whereas acellular products are produced from human cadavers.

Browse detailed report analysis on Wound Care Biologics Industry Development and Future Analysis

Cell-based Therapies

The cells in the body are continuously substituted and replenished by stem cells. These cells possess exceptional posibilities in wound care because of their regenerative capacity. Adult stem cells are transplanted to the wound location either as allogeneic or autologous grafts.

Cell-based therapy focuses on making the wound bed more helpful to healing. The cells that are presently being employed in clinical settings include fibroblasts, keratinocytes, and adipose-derived stromal cells.

Growth Factors

Growth factors play an important role in wound healing. The developments in biotechnology have enabled the application and synthesis of exogenic growth factors for wound healing.

Examples of exogenous growth factors are recombinant human epidermal growth factor (rh EGF) and keratinocyte growth factor (KGF). Though, it is important to acknowledge that growth factors only function well in a properly equipped wound bed.

Scaffolds

Bioartificial scaffolds are formed of components existing in the skin extracellular matrix. These tissue-engineered scaffolds integrate laminin, collagen, fibronectin, hyaluronic acid, and endothelial progenitor cells. Scaffolds, unlike conventional wound dressings, have intrinsic world-healing properties.

Usage Of Biologics

Biologics are gradually becoming very common in wound care. Some major usages of biological materials in wound care are: ‍

Film dressings: Films formed from naturally attained polymers are biodegradable. Additionally, they can also be employed for the delivery of small molecules, growth factors, as well as various other therapeutic medicines.

Hydrogels: Hydrogels are 3D structures composed of different polysaccharides. They can imbibe substantial amounts of water which makes them suitable to preserve a moist wound environment. Because of their biocompatibility, naturally attained polymers are increasingly utilized in the production procedure of hydrogels.

Nanofiber-based dressings: Nanofiber-based dressings possess structural resemblances to extracellular matrices. Synthetic and natural biomaterials are employed to produce nanofibers with the electrospinning method.

In addition, nanofiber-based dressings are becoming more popular in wound care because of their protection from bacterial infection as well as effective exudate management.

Wrapping Up

With the increasing cases of burns & accidents, as well as the rising occurrence of chronic wounds, the wound care biologics industry will continue to grow in the coming years.